跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18 条关于
“NR2B”
全部
18
临床试验
7
药物
4
机构
0
资讯
7
去年
Novel NMDA Receptor Modulator Onfasprodil Shows Rapid Antidepressant Effects with Reduced Side Effects in Phase 2 Trial
10个月前
Neurocrine's NBI-1070770 Fails to Meet Primary Endpoint in Phase II Major Depressive Disorder Trial
去年
FDA Grants Breakthrough Therapy Status to Radiprodil for GRIN-Related Seizure Treatment
去年
GNT Pharma Advances First-in-Class Dual-Action Stroke Therapy Nelonemdaz to Global Phase 3 Trials
去年
GNT Pharma's Nelonemdaz Shows Promise in Improving Stroke Outcomes with Early Administration
2年前
Radiprodil Shows Promise in Reducing Seizure Frequency in GRIN-Related Neurodevelopmental Disorder
2年前
FDA Grants Breakthrough Therapy Designation to Crinecerfont for Congenital Adrenal Hyperplasia